InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Kauffman Michael, Director. Officer active across 2 companies, notably Kezar Life Sciences, Inc.. Cumulatively, 6 filings have been recorded. Total volume traded: €213k. The latest transaction was disclosed on 28 February 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
021,000 shares0
Common Stock
SEC:0001209191-22-014624:0·
€96,7619,079 shares@ €10.65770.056% mcap45.4% of flow
Common Stock
SEC:0001209191-22-011636:0·
€58,2336,764 shares@ €8.60920.034% mcap100.0% of flow
Common Stock
SEC:0001209191-22-008124·
€58,2336,764 shares@ €8.60920.034% mcap27.3% of flow
Common Stock
SEC:0001209191-22-008124:0·
€25,9825,000 shares@ €5.1963100.0% of flow
Common Stock
SEC:0001209191-22-001964·
€25,9825,000 shares@ €5.19630.048% mcap50.0% of flow
Common Stock
SEC:0001209191-22-001964:0·
6 of 6 declarations
About Kauffman Michael
Michael Kauffman serves as a Director at Kezar Life Sciences, Inc. and Karyopharm Therapeutics Inc. In these roles, he participates in the governance of these companies and the formulation of strategies to promote innovation in the life sciences sector. His experience in the biopharmaceutical field is a valuable asset for the boards. He is committed to supporting research and the development of new therapies.
